Understanding the role of minor intron splicing in cortical development
了解小内含子剪接在皮质发育中的作用
基本信息
- 批准号:10368061
- 负责人:
- 金额:$ 36.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Microcephaly is a devastating developmental defect that can be caused by inherited mutations such as those
that inactivate the minor spliceosome or more recently Zika virus infections. In order to better understand the
underlying molecular and cellular defects that cause microcephaly, we must first understand the molecular and
cellular changes during normal development. The current proposal extends our finding that inactivation of the
minor spliceosome in our U11 conditional knockout (cKO) mouse crossed with Emx1-Cre results in
microcephaly observed at birth. We found that the primary cause of the microcephaly is loss of self-amplifying
radial glial cells (RGCs) and delayed death of intermediate progenitor cells (IPCs) without the corresponding
loss of neurons during early cortical development. Despite the complete loss of NPCs by E14, the developing
mutant cortex managed to produce layer IV neurons that are normally born at/after E14. We found that this
shift in neuron production is in conjunction with increased neurogenesis measured by EdU pulse/chase
experiments. Based on these complex phenotypes, we have proposed three aims to test the hypothesis that
minor spliceosome acts in a cell-type specific manner to inform cell cycle regulation, NPC competence, and
neuron production. Experiments proposed in aim 1a are designed to elucidate the precise cell-cycle regulation
of RGCs and IPCs and whether these two cell-types are undergoing self-amplifying or neurogenic cell
divisions. In aim 1b, we explore how the changes in U11-null RGCs and IPCs impact neuron production. In aim
2, the objective is to understand the molecular underpinning of the cell-type specific effect of U11 loss. The one
unique identifier of RGCs is that they divide rapidly compared to the IPCs, so the experiments proposed in aim
2a test the hypothesis that cell cycle speed confers susceptibility to loss of U11. Another possibility that the
experiments proposed in aim 2b is that each cell-type has a unique signature of minor intron-containing genes
(MIGs) that might make cells resistant/susceptible to U1 loss. Finally, RNAseq data showed activation of P53-
medated apoptosis pathway and cell cycle defect in the U11-null tissue. The experiments proposed in aim 3a
test whether rescuing cell cycle defect would prevent P53-mediated apoptosis or is P53-mediated apoptosis
independent of the cell cycle defect. Aim 3b tests the idea that if P53 is ablation, would it rescue cell cycle or
cell death and in turn rescue microcephaly. In all, we will find the role of this novel form of gene regulation in
cortical development and in turn provide insights into microcephaly observed in diseases such as
microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1) and Roifman syndrome that are both
caused by defective minor spliceosome.
小头畸形是一种毁灭性的发育缺陷,可能是由遗传突变引起的
这会使较小的剪接体或最近的寨卡病毒感染失活。为了更好地了解
引起小头畸形的基本分子和细胞缺陷,我们必须首先了解分子和
正常发育过程中的细胞变化。当前的提议扩展了我们的发现
我们的U11条件敲除(CKO)小鼠与EMX1-CRE交叉的次要剪接体导致
出生时观察到的小头畸形。我们发现,小头畸形的主要原因是自我扩增的丧失
径向神经胶质细胞(RGC)和中间祖细胞(IPC)的延迟死亡,没有相应
早期皮质发育期间神经元的丧失。尽管E14完全损失了NPC,但发展
突变皮层设法产生了通常在E14处/之后出生的IV层神经元。我们发现这个
神经元产生的转移与通过EDU脉冲/Chase测得的神经发生增加了
实验。基于这些复杂的表型,我们提出了三个旨在检验假设的目的
较小的剪接体以细胞类型的特定方式起作用,以告知细胞周期调节,NPC能力和
神经元产生。 AIM 1A中提出的实验旨在阐明精确的细胞周期调节
RGC和IPC以及这两种细胞类型是否正在进行自我扩增还是神经源细胞
部门。在AIM 1B中,我们探讨了U11-NULL RGC和IPC的变化如何影响神经元的产生。目标
2,目的是了解U11损耗的细胞类型特异性效应的分子基础。一个
RGC的唯一标识符是它们与IPC相比迅速划分,因此提出的实验在AIM中提出
2a检验了细胞周期速度赋予U11损失的易感性的假设。另一种可能性
AIM 2B中提出的实验是每个细胞类型具有较小内含子内基因的独特特征
(MIG)可能会使细胞具有抗性/易感U1损失。最后,RNASEQ数据显示p53-的激活
U11无效组织中的染色凋亡途径和细胞周期缺陷。 AIM 3A提出的实验
测试拯救细胞周期缺陷是否会预防p53介导的细胞凋亡或p53介导的细胞凋亡
独立于细胞周期缺陷。 AIM 3B测试了一个想法,即如果p53是消融,它会挽救单元周期还是
细胞死亡并救出小头畸形。总的来说,我们将发现这种新型基因调节形式的作用
皮质发育和反过
小头骨骨出现的原始矮人型1型(MOPD1)和Roifman综合征都是
由有缺陷的小剪接体引起。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Disrupted minor intron splicing is prevalent in Mendelian disorders.
- DOI:10.1002/mgg3.1374
- 发表时间:2020-09
- 期刊:
- 影响因子:2
- 作者:Olthof AM;Rasmussen JS;Campeau PM;Kanadia RN
- 通讯作者:Kanadia RN
共 1 条
- 1
RAHUL N KANADIA的其他基金
Understanding the role of minor intron splicing in cortical development
了解小内含子剪接在皮质发育中的作用
- 批准号:98884519888451
- 财政年份:2018
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
The Role of Alternative Splicing Factor Sfrs10 in Neural Development
选择性剪接因子 Sfrs10 在神经发育中的作用
- 批准号:82232058223205
- 财政年份:2011
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
The Role of Alternative Splicing Factor Sfrs10 in Neural Development
选择性剪接因子 Sfrs10 在神经发育中的作用
- 批准号:81887868188786
- 财政年份:2011
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
The Role of Alternative Splicing Factor Sfrs10 in Neural Development
选择性剪接因子 Sfrs10 在神经发育中的作用
- 批准号:84204798420479
- 财政年份:2011
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
The Role of Alternative Splicing Factor Sfrs10 in Neural Development
选择性剪接因子 Sfrs10 在神经发育中的作用
- 批准号:77886307788630
- 财政年份:2010
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
相似国自然基金
VNN1通过内质网非折叠蛋白应激介导单核巨噬细胞凋亡影响创伤患者脓毒症发生的机制研究
- 批准号:82372549
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
- 批准号:32372397
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
MLCK1介导细胞凋亡和自噬影响炎症性肠病进展
- 批准号:82370568
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
EHMT1通过CBX4/MLKL轴调控心肌细胞坏死性凋亡影响心肌缺血再灌注损伤的机制研究
- 批准号:82370288
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
应激颗粒自噬对低氧诱导猪卵泡颗粒细胞凋亡的影响及机制研究
- 批准号:32302741
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:1074877610748776
- 财政年份:2024
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
- 批准号:1071711110717111
- 财政年份:2023
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:1067662810676628
- 财政年份:2023
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
High-dimensional mass imaging of muscle for the mechanistic study of T cells in inclusion body myositis
肌肉高维质量成像用于 T 细胞在包涵体肌炎机制研究中的应用
- 批准号:1066937010669370
- 财政年份:2023
- 资助金额:$ 36.61万$ 36.61万
- 项目类别:
Fibroblast-derived laminin regulates blood-brain barrier integrity and fibroblast biology in hemorrhagic brain
成纤维细胞衍生的层粘连蛋白调节出血脑中的血脑屏障完整性和成纤维细胞生物学
- 批准号:1074928010749280
- 财政年份:2023
- 资助金额:$ 36.61万$ 36.61万
- 项目类别: